Target Name: MIR2861
NCBI ID: G100422910
Review Report on MIR2861 Target / Biomarker Content of Review Report on MIR2861 Target / Biomarker
MIR2861
Other Name(s): MIRN2861 | microRNA 2861 | hsa-mir-2861 | BMND15 | hsa-miR-2861 | MicroRNA 2861

Introduction to MIR2861, A Potential Drug Target

In recent years, researchers and scientists have made significant strides in the field of medical science, particularly in the study of drug targets and biomarkers. These key components provide valuable insights into disease mechanisms and pave the way for the development of novel therapeutic interventions. One such intriguing biomarker that has gained considerable attention is MIR2861.

What is MIR2861?

MIR2861, also known as microRNA 2861, is a small non-coding RNA molecule encoded in the human genome. MicroRNAs are a class of molecules responsible for regulating gene expression by binding to messenger RNA (mRNA) and inhibiting its translation into protein. MIR2861 was first identified in a genome-wide sequencing study and has since been associated with various physiological and pathological processes.

Role as a Biomarker

One of the most important applications of MIR2861 lies in its potential use as a biomarker. Biomarkers are measurable indicators of biological processes or conditions and play a crucial role in identifying diseases, monitoring disease progression, predicting therapeutic response, and assessing treatment outcomes. Several studies have suggested that MIR2861 levels in various body fluids, such as blood, urine, and saliva, can serve as a diagnostic and prognostic biomarker for numerous diseases.

MIR2861 as a Diagnostic Biomarker

Over the years, researchers have investigated the diagnostic value of MIR2861 in different diseases. For instance, a study published in the Journal of Cancer Research and Clinical Oncology demonstrated that MIR2861 expression was significantly downregulated in hepatocellular carcinoma (HCC) tissues compared to adjacent normal liver tissues. Moreover, the study observed that low MIR2861 expression levels were associated with worse overall survival, suggesting its potential as a diagnostic biomarker for HCC. Similar findings have been reported in other malignancies, including pancreatic cancer and breast cancer.

MIR2861 as a Prognostic Biomarker

Apart from its diagnostic applications, MIR2861 has also shown promise as a prognostic biomarker in various diseases. In a study published in Molecular Medicine Reports, researchers investigated the expression pattern of MIR2861 in patients with colorectal cancer (CRC) and found a significant inverse correlation between MIR2861 levels and CRC overall survival. Further analysis revealed that low MIR2861 expression was associated with more advanced tumor stages and lymph node metastasis. These findings suggest that MIR2861 could serve as a reliable prognostic biomarker for CRC.

Targeting MIR2861 for Therapeutic Intervention

In addition to its role as a biomarker, MIR2861 has also garnered attention as a potential drug target. Researchers believe that manipulating MIR2861 expression levels could offer therapeutic benefits in various diseases. For instance, a study published in the Journal of Clinical Investigation investigated the role of MIR2861 in cardiac hypertrophy and demonstrated that overexpression of MIR2861 attenuated pathological cardiac remodeling. This suggests that upregulating MIR2861 levels could potentially serve as a therapeutic strategy for preventing or treating cardiac hypertrophy.

Challenges and Future Directions

While the potential applications of MIR2861 as a biomarker and drug target are indeed promising, several challenges still need to be addressed. Firstly, standardization of detection methods and establishing reference ranges for MIR2861 expression levels are crucial for clinical utility. Moreover, gaining a deeper understanding of the underlying molecular mechanisms through which MIR2861 functions is essential for the development of targeted therapeutic approaches.

Conclusion

In conclusion, MIR2861 holds tremendous potential as both a biomarker and a drug target. Its unique characteristics and involvement in various physiological and pathological processes make it an intriguing molecule in the field of biomedical research. As further studies unravel its role in different diseases and pave the way for precise therapeutic interventions, MIR2861 could significantly impact the diagnosis, prognosis, and treatment of numerous ailments. Continued research in this area will undoubtedly shed more light on the multifaceted nature of MIR2861 and its applications in personalized medicine.

Protein Name: MicroRNA 2861

The "MIR2861 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR2861 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166